TipRanks
Vericel Corp (DE:ATQP)
FRANKFURT:ATQP
Germany Market
ATQP
Vericel
RESEARCH TOOLSreports

Vericel (ATQP) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

ATQP Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Vericel
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ATQP Stock 12 Month Forecast

Average Price Target

€53.64
▲(48.19% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Vericel in the last 3 months. The average price target is €53.64 with a high forecast of €64.11 and a low forecast of €46.30. The average price target represents a 48.19% change from the last price of €36.20.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"25":"€25","35":"€35","45":"€45","55":"€55","65":"€65"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":64.1051892,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€64.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":53.6435784625,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€53.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":46.2981922,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€46.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[25,35,45,55,65],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.4,37.60809147692308,39.81618295384615,42.02427443076923,44.232365907692305,46.440457384615385,48.64854886153846,50.85664033846154,53.06473181538462,55.27282329230769,57.480914769230765,59.689006246153845,61.897097723076925,{"y":64.1051892,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.4,36.80335218942307,38.206704378846155,39.61005656826923,41.013408757692304,42.416760947115385,43.82011313653846,45.22346532596154,46.626817515384616,48.03016970480769,49.43352189423077,50.836874083653846,52.24022627307693,{"y":53.6435784625,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,35.4,36.238322476923074,37.076644953846156,37.91496743076923,38.753289907692306,39.59161238461539,40.42993486153846,41.26825733846154,42.10657981538462,42.944902292307695,43.78322476923077,44.62154724615385,45.45986972307693,{"y":46.2981922,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":26.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.6,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.2,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.4,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€64.11Average Price Target€53.64Lowest Price Target€46.30
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on DE:ATQP
Richard Newitter
Truist Financial
Truist Financial
€51.64→€46.3
Buy
27.90%
Upside
Reiterated
10/14/26
Vericel price target lowered to $52 from $58 at TruistVericel price target lowered to $52 from $58 at Truist
Leerink Partners Analyst forecast on DE:ATQP
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
€52.53
Buy
45.11%
Upside
Reiterated
09/18/26
Leerink Partners Sticks to Their Buy Rating for Vericel (VCEL)
TD Cowen Analyst forecast on DE:ATQP
Josh Jennings
TD Cowen
TD Cowen
€51.64
Buy
42.65%
Upside
Reiterated
09/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (NYSE: DNA) and Vericel (NASDAQ: VCEL)
H.C. Wainwright Analyst forecast on DE:ATQP
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
€62.32→€64.11
Buy
77.09%
Upside
Reiterated
07/31/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (NASDAQ: VCEL), Sarepta Therapeutics (NASDAQ: SRPT) and Neumora Therapeutics, Inc. (NASDAQ: NMRA)
Canaccord Genuity Analyst forecast on DE:ATQP
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
€51.64
Buy
42.65%
Upside
Reiterated
06/24/26
Vericel Buy Rating Reiterated as New Burlington Facility Underpins Long-Term Growth; $58 Price Target Maintained
BTIG Analyst forecast on DE:ATQP
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
04/05/26
Hold Rating on Vericel: BARDA Contract Validates NexoBrid but Premium Valuation Limits Upside
Ladenburg Thalmann & Co. Analyst forecast on DE:ATQP
Unknown Analyst
Ladenburg Thalmann & Co.
Not Ranked
Ladenburg Thalmann & Co.
€55.2
Buy
52.49%
Upside
Reiterated
02/27/26
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on DE:ATQP
Richard Newitter
Truist Financial
Truist Financial
€51.64→€46.3
Buy
27.90%
Upside
Reiterated
10/14/26
Vericel price target lowered to $52 from $58 at TruistVericel price target lowered to $52 from $58 at Truist
Leerink Partners Analyst forecast on DE:ATQP
Unknown Analyst
Leerink Partners
Not Ranked
Leerink Partners
€52.53
Buy
45.11%
Upside
Reiterated
09/18/26
Leerink Partners Sticks to Their Buy Rating for Vericel (VCEL)
TD Cowen Analyst forecast on DE:ATQP
Josh Jennings
TD Cowen
TD Cowen
€51.64
Buy
42.65%
Upside
Reiterated
09/04/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (NYSE: DNA) and Vericel (NASDAQ: VCEL)
H.C. Wainwright Analyst forecast on DE:ATQP
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
€62.32→€64.11
Buy
77.09%
Upside
Reiterated
07/31/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (NASDAQ: VCEL), Sarepta Therapeutics (NASDAQ: SRPT) and Neumora Therapeutics, Inc. (NASDAQ: NMRA)
Canaccord Genuity Analyst forecast on DE:ATQP
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
€51.64
Buy
42.65%
Upside
Reiterated
06/24/26
Vericel Buy Rating Reiterated as New Burlington Facility Underpins Long-Term Growth; $58 Price Target Maintained
BTIG Analyst forecast on DE:ATQP
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
04/05/26
Hold Rating on Vericel: BARDA Contract Validates NexoBrid but Premium Valuation Limits Upside
Ladenburg Thalmann & Co. Analyst forecast on DE:ATQP
Unknown Analyst
Ladenburg Thalmann & Co.
Not Ranked
Ladenburg Thalmann & Co.
€55.2
Buy
52.49%
Upside
Reiterated
02/27/26
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
SIBNSI-Bone
IMUXImmunic
MDWDMediwound
HROWHarrow Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Vericel

3 Months
Josh JenningsTD Cowen
Success Rate
9/19 ratings generated profit
47%
Average Return
+0.45%
Copying Josh Jennings's trades and holding each position for 3 Months would result in 47.37% of your transactions generating a profit, with an average return of +0.45% per trade.
1 Year
Josh JenningsTD Cowen
Success Rate
11/19 ratings generated profit
58%
Average Return
-1.51%
Copying Josh Jennings's trades and holding each position for 1 Year would result in 57.89% of your transactions generating a profit, with an average return of -1.51% per trade.
2 Years
Josh JenningsTD Cowen
Success Rate
10/19 ratings generated profit
53%
Average Return
+0.68%
Copying Josh Jennings's trades and holding each position for 2 Years would result in 52.63% of your transactions generating a profit, with an average return of +0.68% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATQP Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
7
4
1
1
0
Buy
4
6
6
6
4
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
10
7
7
4
In the current month, ATQP has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ATQP average Analyst price target in the past 3 months is 53.64.
Each month's total comprises the sum of three months' worth of ratings.

ATQP Financial Forecast

ATQP Earnings Forecast

Next quarter’s earnings estimate for ATQP is €0.05 with a range of €0.02 to €0.09. The previous quarter’s EPS was €0.04. ATQP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.
Next quarter’s earnings estimate for ATQP is €0.05 with a range of €0.02 to €0.09. The previous quarter’s EPS was €0.04. ATQP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.

ATQP Sales Forecast

Next quarter’s sales forecast for ATQP is €69.40M with a range of €68.87M to €69.80M. The previous quarter’s sales results were €68.96M. ATQP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.
Next quarter’s sales forecast for ATQP is €69.40M with a range of €68.87M to €69.80M. The previous quarter’s sales results were €68.96M. ATQP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ATQP has Performed in-line its overall industry.

ATQP Stock Forecast FAQ

What is DE:ATQP’s average 12-month price target, according to analysts?
Based on analyst ratings, Vericel Corp’s 12-month average price target is 53.64.
    What is DE:ATQP’s upside potential, based on the analysts’ average price target?
    Vericel Corp has 48.19% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Vericel Corp a Buy, Sell or Hold?
          Vericel Corp has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Vericel Corp’s share price target?
            The average share price target for Vericel Corp is 53.64. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €64.11 ,and the lowest forecast is €46.30. The average share price target represents 48.19% Increase from the current price of €36.2.
              What do analysts say about Vericel Corp?
              Vericel Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Vericel Corp?
                To buy shares of DE:ATQP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.